Venous valves: Where do things stand as endovascular device enters clinical trial stage?

David Dexter (Sentara Vascular Specialists, Norfolk, Virginia) speaks to Venous News at CX 2026 following recent faltering steps in a decades-long march toward a viable venous valve replacement option making it to market. Dexter was in the CX Studio shortly after giving “an honest update” during the annual symposium.